Search
forCommunity 5 of 14
- European Medecine Agency (EMA) review of Finasteride and Dutasteride
- Heads up for EU Fin users: Finasteride prescription has been toughened up in France
- EMA is re-examining Winlevi (clascoterone at lower concentration)
- EMAs Response to my Mail i sent them explaining the importance of Finasteride for hairloss in EU
- Eucapil/fluridil - have you heard of it? What’s your opinion?
Research 10 of 1000+
- Is finasteride intake associated with penile curvature/peyronie’s disease? Assessment of both the food and drug administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- Cyproterone acetate and risk of meningioma: a nationwide cohort study
- Prescription Appropriateness of Cyproterone Acetate/Ethinylestradiol in Primary Care: A Population-Based Study in Italy
- New therapies for alopecia areata
- Finasteride-Induced Neuropsychiatric Reactions Are Well Established
- Finasteride-Induced Neuropsychiatric Reactions Are Well Established
- Post-finasteride syndrome: pharmacists must lead the conversation on patient safety
- Ethnopharmacy for skin diseases and cosmetics in Lithuania: access to health care and risk of self-treatment
- Current Status of PRP Manufacturing Requirements & European Regulatory Frameworks: Practical Tools for the Appropriate Implementation of PRP Therapies in Musculoskeletal Regenerative Medicine